Robb Knie - Net Worth and Insider Trading

Robb Knie Net Worth

The estimated net worth of Robb Knie is at least $40,253 dollars as of 2024-04-30. Robb Knie is the CEO and President of Hoth Therapeutics Inc and owns about 33,130 shares of Hoth Therapeutics Inc (HOTH) stock worth over $40,253. Details can be seen in Robb Knie's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robb Knie has not made any transactions after 2022-09-19 and currently still holds the listed stock(s).

Transaction Summary of Robb Knie

To

Robb Knie Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robb Knie owns 4 companies in total, including Hoth Therapeutics Inc (HOTH) , Inventergy Global Inc (INVT) , and FoxWayne Enterprises Acquisition Corp (FOXW) among others .

Click here to see the complete history of Robb Knie’s form 4 insider trades.

Insider Ownership Summary of Robb Knie

Ticker Comapny Transaction Date Type of Owner
HOTH Hoth Therapeutics Inc 2022-09-19 director & CEO and President
INVT Inventergy Global Inc 2014-06-06 director
FOXW FoxWayne Enterprises Acquisition Corp 2021-01-19 director & Chairman and CEO
FOXWU FoxWayne Enterprises Acquisition Corp 2021-01-19 director & Chairman and CEO

Robb Knie Latest Holdings Summary

Robb Knie currently owns a total of 1 stock. Robb Knie owns 33,130 shares of Hoth Therapeutics Inc (HOTH) as of September 19, 2022, with a value of $40,253.

Latest Holdings of Robb Knie

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HOTH Hoth Therapeutics Inc 2022-09-19 33,130 1.22 40,253

Holding Weightings of Robb Knie


Robb Knie Form 4 Trading Tracker

According to the SEC Form 4 filings, Robb Knie has made a total of 2 transactions in Hoth Therapeutics Inc (HOTH) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Hoth Therapeutics Inc is the acquisition of 400 shares on September 19, 2022, which cost Robb Knie around $3,900.

Insider Trading History of Robb Knie

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robb Knie Trading Performance

GuruFocus tracks the stock performance after each of Robb Knie's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robb Knie is -66.77%. GuruFocus also compares Robb Knie's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robb Knie within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Robb Knie's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Robb Knie

Average Return

-81.86%

Average return per transaction

Outperforming Transactions

0%

0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -14.25 -66.77 -77.71 -81.86
Relative Return to S&P 500(%) -7.88 -65.45 -79.05 -96.28

Robb Knie Ownership Network

Ownership Network List of Robb Knie

No Data

Ownership Network Relation of Robb Knie


Robb Knie Owned Company Details

What does Hoth Therapeutics Inc do?

Who are the key executives at Hoth Therapeutics Inc?

Robb Knie is the director & CEO and President of Hoth Therapeutics Inc. Other key executives at Hoth Therapeutics Inc include Chief Scientific Officer Stefanie Johns , 10 percent owner Spherix Inc , and Chief Financial Officer David S. Briones .

Hoth Therapeutics Inc (HOTH) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Hoth Therapeutics Inc (HOTH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Hoth Therapeutics Inc (HOTH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Hoth Therapeutics Inc (HOTH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Hoth Therapeutics Inc Insider Transactions

No Available Data

Robb Knie Mailing Address

Above is the net worth, insider trading, and ownership report for Robb Knie. You might contact Robb Knie via mailing address: C/o Inventergy Global, Inc., 900 East Hamilton Avenue Suite 180, Campbell Ca 95008.

Discussions on Robb Knie

No discussions yet.